Late diagnosis of CKD and associated survival after initiation of renal replacement therapy in Kazakhstan: analysis of nationwide electronic healthcare registry 2014-2019.


Journal

Renal failure
ISSN: 1525-6049
Titre abrégé: Ren Fail
Pays: England
ID NLM: 8701128

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 4 9 2024
pubmed: 4 9 2024
entrez: 4 9 2024
Statut: ppublish

Résumé

Chronic kidney disease (CKD) presents a significant global health challenge, often progressing to end-stage renal disease (ESRD) necessitating renal replacement therapy (RRT). Late referral (LR) to nephrologists before RRT initiation is linked with adverse outcomes. However, data on CKD diagnosis and survival post-RRT initiation in Kazakhstan remain limited. This study aims to investigate the impact of late CKD diagnosis on survival prognosis after RRT initiation. Data were acquired from the Unified National Electronic Health System (UNEHS) for CKD patients initiating RRT between 2014 and 2019. Survival post-RRT initiation was assessed using the Cox Proportional Hazards Model. Totally, 211,655 CKD patients were registered in the UNEHS databases and 9,097 (4.3%) needed RRT. The most prevalent age group among RRT patients is 45-64 years, with a higher proportion of males (56%) and Kazakh ethnicity (64%). Seventy-four percent of patients were diagnosed late. The median follow-up time was 537 (IQR: 166-1101) days. Late diagnosis correlated with worse survival (HR = 1.18,

Identifiants

pubmed: 39229925
doi: 10.1080/0886022X.2024.2398182
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2398182

Auteurs

Valdemir Kim (V)

Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Gulnur Zhakhina (G)

Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Arnur Gusmanov (A)

Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Yesbolat Sakko (Y)

Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Mariyam Kim (M)

Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Meruyert Madikenova (M)

Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Clinical Academic Department of Internal Medicine, CF "University Medical Center", Astana, Kazakhstan.

Zhannat Kuanshaliyeva (Z)

Clinical Academic Department of Internal Medicine, CF "University Medical Center", Astana, Kazakhstan.

Alpamys Issanov (A)

School of Population and Public Health, University of British Columbia, Vancouver, Canada.

Ainur Assan (A)

Department of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan, Kazakhstan.

Marina Khvan (M)

Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.

Altay Nabiyev (A)

Clinical Academic Department of Internal Medicine, CF "University Medical Center", Astana, Kazakhstan.

Sholpan Altynova (S)

Department of Medical and Regulatory Affairs, CF "University Medical Center", Astana, Kazakhstan.

Abduzhappar Gaipov (A)

Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Clinical Academic Department of Internal Medicine, CF "University Medical Center", Astana, Kazakhstan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH